{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:27:39Z","timestamp":1790800059347,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biopha.2017.11.090","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T03:36:43Z","timestamp":1512531403000},"page":"1246-1252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14"],"prefix":"10.1016","volume":"96","author":[{"given":"Bo","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biopha.2017.11.090_bib0005","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jvir.2017.03.002","article-title":"Molecular mechanisms and targets of therapy for hepatocellular carcinoma","volume":"28","author":"Klungboonkrong","year":"2017","journal-title":"J. Vasc. Intervent. Radiol.: JVIR"},{"issue":"6","key":"10.1016\/j.biopha.2017.11.090_bib0010","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4254\/wjh.v9.i6.300","article-title":"Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma","volume":"9","author":"Gera","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.biopha.2017.11.090_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fmed.2017.00010","article-title":"Tissue biomarkers in hepatocellular tumors: which, when, and how","volume":"4","author":"Di Tommaso","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2017.11.090_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/JHC.S105777","article-title":"Screening for hepatocellular carcinoma: patient selection and perspectives","volume":"4","author":"Fateen","year":"2017","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.090_bib0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/CCO.0000000000000378","article-title":"Advances in management of hepatocellular carcinoma","volume":"29","author":"Allaire","year":"2017","journal-title":"Curr. Opin. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2017.11.090_bib0030","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v7.i9.1157","article-title":"Hepatocellular carcinoma: advances in diagnosis, management, and long term outcome","volume":"7","author":"Bodzin","year":"2015","journal-title":"World J. Hepatol."},{"issue":"Suppl 2","key":"10.1016\/j.biopha.2017.11.090_bib0035","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000440633","article-title":"Recent advances in the management of chronic hepatitis B including suppression of hepatocellular carcinoma by entecavir and interferon","volume":"89","author":"Kim","year":"2015","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.biopha.2017.11.090_bib0040","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000445275","article-title":"Treatment of hepatocellular carcinoma","volume":"34","author":"Diaz-Gonzalez","year":"2016","journal-title":"Dig. Dis."},{"issue":"14","key":"10.1016\/j.biopha.2017.11.090_bib0045","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1080\/14656566.2016.1225722","article-title":"Systemic treatment for advanced hepatocellular carcinoma: the search of new agents to join sorafenib in the effective therapeutic armamentarium","volume":"17","author":"Ribeiro de Souza","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.090_bib0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.090_bib0055","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/hepr.12737","article-title":"MetastamiRs: a promising choice for antihepatocellular carcinoma nucleic acid drug development","volume":"47","author":"Wu","year":"2017","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.biopha.2017.11.090_bib0060","first-page":"257","article-title":"MicroRNA and hepatocellular carcinoma: biology and prognostic significance","volume":"57","author":"Milazzo","year":"2011","journal-title":"Minerva Gastroenterol. Dietol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.090_bib0065","first-page":"863","article-title":"Hepatocellular carcinoma: a comprehensive review of biomarkers, clinical aspects, and therapy","volume":"18","author":"Tunissiolli","year":"2017","journal-title":"Asian Pac. J. Cancer Prevent.: APJCP"},{"key":"10.1016\/j.biopha.2017.11.090_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179299X16684640","article-title":"Biomarkers for hepatocellular carcinoma","volume":"9","author":"Lou","year":"2017","journal-title":"Biomark. Cancer"},{"issue":"5","key":"10.1016\/j.biopha.2017.11.090_bib0075","doi-asserted-by":"crossref","first-page":"971","DOI":"10.17219\/acem\/36460","article-title":"MicroRNAs in the occurrence and development of primary hepatocellular carcinoma","volume":"25","author":"Xu","year":"2016","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2017.11.090_bib0080","doi-asserted-by":"crossref","first-page":"38311","DOI":"10.1038\/srep38311","article-title":"Biomarker MicroRNAs for diagnosis, prognosis and treatment of hepatocellular carcinoma: a functional survey and comparison","volume":"6","author":"Shen","year":"2016","journal-title":"Sci. Rep."},{"issue":"15","key":"10.1016\/j.biopha.2017.11.090_bib0085","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.3748\/wjg.v22.i15.3907","article-title":"MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma","volume":"22","author":"Fiorino","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.090_bib0090","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.clinre.2016.02.001","article-title":"Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"40","author":"He","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.090_bib0095","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1186\/s12885-016-2801-4","article-title":"miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)","volume":"16","author":"Zhu","year":"2016","journal-title":"BMC cancer"},{"key":"10.1016\/j.biopha.2017.11.090_bib0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.biopha.2016.04.034","article-title":"miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2","volume":"81","author":"Huang","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2017.11.090_bib0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2016.02.043","article-title":"MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK\/AKT signaling in hepatocellular carcinoma","volume":"375","author":"Chen","year":"2016","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.biopha.2017.11.090_bib0110","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.3892\/or.2017.5596","article-title":"Exploration of miR-1202 and miR-196a in human endometrial cancer based on high throughout gene screening analysis","volume":"37","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2017.11.090_bib0115","doi-asserted-by":"crossref","first-page":"25997","DOI":"10.1038\/srep25997","article-title":"microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection","volume":"6","author":"Hamam","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2017.11.090_bib0120","doi-asserted-by":"crossref","first-page":"e0130472","DOI":"10.1371\/journal.pone.0130472","article-title":"Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer","volume":"10","author":"Tokuhisa","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2017.11.090_bib0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.090_bib0130","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/hep.21691","article-title":"Identification of PFTAIRE protein kinase 1, a novel cell division cycle-2 related gene, in the motile phenotype of hepatocellular carcinoma cells","volume":"46","author":"Pang","year":"2007","journal-title":"Hepatology"},{"issue":"44","key":"10.1016\/j.biopha.2017.11.090_bib0135","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1038\/onc.2011.161","article-title":"A novel interplay between oncogenic PFTK1 protein kinase and tumor suppressor TAGLN2 in the control of liver cancer cell motility","volume":"30","author":"Leung","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.090_bib0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bbrc.2014.05.002","article-title":"PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma","volume":"449","author":"Sun","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2017.11.090_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/15384047.2016.1276134","article-title":"Tumor markers for early diagnosis for brain metastasis of hepatocellular carcinoma: a case series and literature review for effective loco-regional treatment","volume":"18","author":"Kamimura","year":"2017","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.090_bib0150","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.090_bib0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14348\/molcells.2016.2161","article-title":"miR-101 inhibiting cell proliferation, migration and invasion in hepatocellular carcinoma through downregulating girdin","volume":"39","author":"Cao","year":"2016","journal-title":"Mol. Cells"},{"issue":"1","key":"10.1016\/j.biopha.2017.11.090_bib0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2015.04.023","article-title":"MiR-429 increases the metastatic capability of HCC via regulating classic Wnt pathway rather than epithelial-mesenchymal transition","volume":"364","author":"Tang","year":"2015","journal-title":"Cancer Lett."},{"issue":"27","key":"10.1016\/j.biopha.2017.11.090_bib0165","doi-asserted-by":"crossref","first-page":"44050","DOI":"10.18632\/oncotarget.17211","article-title":"Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis","volume":"8","author":"Guo","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biopha.2017.11.090_bib0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12032-013-0577-9","article-title":"Upregulation of miR-2861 and miR-451 expression in papillary thyroid carcinoma with lymph node metastasis","volume":"30","author":"Wang","year":"2013","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2017.11.090_bib0175","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317697565","article-title":"MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A","volume":"39","author":"Quan","year":"2017","journal-title":"Tumour Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217344724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217344724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:16:52Z","timestamp":1778242612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217344724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":35,"alternative-id":["S0753332217344724"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.090","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.11.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}